InvestorsHub Logo
Followers 0
Posts 596
Boards Moderated 0
Alias Born 05/15/2017

Re: None

Thursday, 08/22/2019 12:11:46 PM

Thursday, August 22, 2019 12:11:46 PM

Post# of 1602
Great move and still undepriced ,,,, FDA Decision for IBS-C drug in 3 Weeks and Phase 3 readout of the hyperphosphatemia trial imminent (this Quarter)

Results from the AMPLIFY clinical trial, the company's Phase 3 clinical trial evaluating tenapanor's efficacy in combination with phosphate binders, are currently expected to be announced in the third quarter of 2019.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARDX News